Major egg antigens are immunogenic proteins found in eggs that can elicit specific immune responses. In parasitic infections like schistosomiasis, egg antigens from Schistosoma mansoni play crucial roles in disease pathogenesis by triggering CD4+ T helper cell-mediated granulomatous responses to tissue-deposited eggs. These antigens have significant potential for desensitizing the CD4+ Th cells that mediate granuloma formation, which may prevent or ameliorate clinical manifestations of schistosomiasis . In avian systems, eggs contain maternally-derived antibodies that can be studied as models for passive immunity and potential therapeutic applications.
Several egg antigens from S. mansoni have been characterized, with two of particular prominence:
A 62-kDa egg antigen - This antigen elicits a strong proliferative response in CD4+ T helper cells from infected mice of the BL/6 strain. Upon analysis, this antigen was found to share sequence identity with phosphoenolpyruvate carboxykinase (PEPCK) from organisms like Caenorhabditis elegans and Treponema pallidum .
Smp40 - A major egg antigen with a molecular weight of approximately 40 kDa. Structural analysis reveals that the C-terminal portion of Smp40 (residues 130 onward) contains two alpha crystallin domains with a fold consisting of eight beta strands sandwiched in two sheets forming a Greek key pattern .
Birds produce a specific type of antibody called IgY that appears in both their serum and eggs. IgY is functionally comparable to IgG in mammals but possesses several advantageous properties for research and therapeutic applications:
IgY does not trigger allergic reactions or set off immune responses when injected into humans.
IgY antibodies can be collected non-invasively through eggs (approximately 300 per hen annually).
The production system can be rapidly updated to respond to new variants by hyperimmunizing hens with updated antigens .
The cytokine profile elicited by egg antigens provides critical insight into their role in disease pathogenesis and potential therapeutic applications. In studies of Smp40 stimulation of peripheral blood mononuclear cells from S. mansoni-infected patients, researchers observed:
No statistically significant differences in interferon-γ, IL-4, and IL-13 levels compared to control groups (P > 0.05 for each).
Significant increases in IL-5 (P = 0.006) and IL-10 (P < 0.001) levels compared to control groups .
This specific cytokine profile is associated with reduced collagen deposition, decreased fibrosis, and inhibition of granuloma formation, suggesting potential applications for Smp40 as an anti-pathology vaccine candidate for schistosomiasis .
There is considerable variation in the severity of disease and T-cell responses to egg antigens among different mouse strains and infected individuals. In BL/6 mice, egg granulomas are relatively small, whereas strains like C3H and CBA develop larger granulomas. Specific egg antigens elicit strain-specific responses:
The 62-kDa antigen (PEPCK-like) elicits a particularly strong response in CD4+ Th cells from BL/6 mice, inducing a mixed Th-1 and Th-2 type cytokine profile .
Sm-p40, another abundant egg component, has been identified as a small heat shock protein with homologies to alpha-crystallins. This antigen elicits a strong Th-1 type response specifically in C3H and CBA mice, which characteristically develop larger egg granulomas .
These strain-specific responses suggest that the immune response in schistosomiasis results from sensitization to egg antigens that vary considerably in immunogenicity from strain to strain, highlighting the complexity of host-parasite immunological interactions .
Purification and characterization of novel egg antigens requires careful experimental design:
Fractionation methods: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is effective for initial separation, resulting in the isolation of distinct components with different molecular masses.
Functional screening: T-cell hybridomas can serve as monoclonal probes to identify which specific egg antigen components are recognized by immune cells.
Protein sequencing: After isolation, partial digestion with endoproteinases followed by amino acid sequencing can help identify the antigen through homology with known proteins in databases.
Structural characterization: For antigens like Smp40, three-dimensional structure elucidation can be achieved through molecular modeling based on similarity with template proteins (such as small heat shock proteins) in protein databases .
The isolation of antibodies from immunized chicken eggs involves several key steps:
Egg collection and yolk separation: Separate the yolk from the egg white using an egg separator. The yolk is then wrapped in cotton gauze, and the yolk membrane is pierced to collect the yolk content .
Initial processing: Make a 1/50 dilution of egg yolk in an appropriate buffer solution (such as TBS) .
Antibody detection: Techniques such as indirect ELISA can be used to detect the presence of specific antibodies in the egg yolk:
Coat microtiter plate wells with target antigen
Block with appropriate blocking buffer
Add serial dilutions of the egg yolk sample
Wash and add secondary antibody (e.g., rabbit anti-chicken IgG conjugated to alkaline phosphatase)
Develop with chromogenic substrate
Purification: Methods such as precipitation with polyethylene glycol followed by ion-exchange chromatography can be used to purify IgY antibodies from egg yolk.
Effective immunization protocols for hens typically include:
Antigen preparation: Prepare the target antigen in an appropriate form for immunization. For complex antigens like viral proteins, consider using recombinant versions or specific domains.
Immunization regimen: A typical protocol involves:
Timing of egg collection: Antibody production in eggs typically begins 2-3 weeks after immunization, with peak titers occurring after booster immunizations. In SARS-CoV-2 studies, researchers measured antibodies in egg yolks three and six weeks after the last immunization .
Sample analysis: Test both serum samples from hens and egg yolks to confirm antibody production and specificity.
To evaluate antibody specificity and functionality, researchers should consider:
The development of vaccines against schistosomiasis using egg antigen-specific antibodies involves:
Antigen selection: Identify appropriate egg antigens that can induce protective immunity. Smp40 has shown promise as an anti-pathology vaccine candidate due to its ability to induce cytokine profiles associated with reduced fibrosis and granuloma formation .
Delivery strategies: Consider various formulations and delivery routes for optimal immune responses.
Immune response modulation: Target specific cytokine profiles that reduce pathology. Smp40 stimulation generates increases in IL-5 and IL-10 levels, which are associated with reduced collagen deposition and decreased fibrosis .
Efficacy assessment: Evaluate the ability of vaccine candidates to prevent or reduce granuloma formation, fibrosis, and other pathological outcomes in appropriate animal models.
Recent advances include:
COVID-19 applications: Researchers at UC Davis have produced antibodies against the SARS-CoV-2 spike protein in hen eggs. These antibodies could potentially be used as:
Production advantages:
Cost-effectiveness: Low cost of production in hen eggs compared to mammalian expression systems
Scalability: A single hen can produce approximately 300 eggs per year, yielding substantial amounts of antibodies
Adaptability: The system can be rapidly updated to respond to new variants by hyperimmunizing hens with updated antigens
Clinical development: